Adastra Labs Holdings Ltd. (XTRX) AI Stock Analysis

• Market Cap: C$1.12M
• Dividend Yield: N/A
• Average Volume (3M): 323.00
• Price to Earnings (P/E): ―
• Beta (1Y): 0.38
• Revenue Growth: -33.88%
• EPS Growth: -449.86%
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): -0.11
• Shares Outstanding: 5,597,050
• 10 Day Avg. Volume: 51
• 30 Day Avg. Volume: 323
• PEG Ratio: >-0.01
• Price to Book (P/B): 8.69
• Price to Sales (P/S): 0.51
• P/FCF Ratio: 30.71
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 45 Neutral
• Price Target: C$0.21 ▼(-14.58% Downside)
• Action: Reiterated Date: 12/18/25
• Date: Action: Reiterated 12/18/25

The overall stock score is primarily impacted by the company's poor financial performance, which is the most significant factor. Technical analysis provides some moderate support, but the negative valuation metrics further weigh down the score. The absence of earnings call data and corporate events means these factors do not influence the score.

Positive Factors

Specialized B2B extraction and formulation

Adastra Labs operates a focused, specialty business supplying refined cannabinoid ingredients to manufacturers. That B2B ingredient model is durable: it relies on production know-how and contract relationships rather than retail foot traffic, supporting steady demand from downstream brands and potential for long-term supply agreements.

Negative Factors

Declining revenue and large losses

Revenues are declining materially while net margins are deeply negative, indicating the business is shrinking while losing cash on sales. Sustained top-line contraction combined with heavy losses undermines scale economics, limits reinvestment capacity, and makes achieving a durable turnaround more difficult without clear demand or margin recovery.

Adastra Labs Holdings Ltd. Business Overview & Revenue Model

Company Description

Adastra Labs Holdings Ltd. (XTRX) is a Canadian company focused on the research, development, and production of cannabis-related products and services. Operating primarily in the cannabis sector, Adastra Labs engages in the extraction and formulat...

Read more

Adastra Labs Holdings Ltd. (XTRX) is a Canadian company focused on the research, development, and production of cannabis-related products and services. Operating primarily in the cannabis sector, Adastra Labs engages in the extraction and formulat...

How the Company Makes Money

Adastra Labs generates revenue through multiple streams, primarily from the sale of its cannabis extracts and formulated products to both wholesale and retail customers. The company engages in direct sales to licensed cannabis retailers, as well a...

Read more

Adastra Labs generates revenue through multiple streams, primarily from the sale of its cannabis extracts and formulated products to both wholesale and retail customers. The company engages in direct sales to licensed cannabis retailers, as well a...

Adastra Labs Holdings Ltd. Financial Statement Overview

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Dec 2020
Income Statement
Total Revenue	16.86M	24.84M	22.22M	13.30M	5.63M	2.50M
Gross Profit	5.44M	8.31M	7.57M	6.11M	1.94M	785.58K
EBITDA	-13.19M	-11.21M	-1.41M	-2.62M	-1.39M	-7.07M
Net Income	-14.49M	-13.24M	-3.54M	-4.28M	-2.75M	-8.07M
Balance Sheet
Total Assets	16.01M	19.34M	32.34M	31.80M	28.76M	13.74M
Cash, Cash Equivalents and Short-Term Investments	786.60K	1.30M	1.38M	1.01M	744.54K	1.15M
Total Debt	3.57M	3.62M	3.64M	3.95M	3.59M	2.50M
Total Liabilities	16.96M	17.89M	17.66M	13.57M	6.38M	3.65M
Stockholders Equity	-947.25K	1.45M	14.69M	18.23M	22.37M	10.09M
Cash Flow
Free Cash Flow	-101.81K	410.06K	1.18M	694.07K	-1.64M	-4.63M
Operating Cash Flow	-315.28K	826.23K	1.86M	1.32M	-1.05M	-2.83M
Investing Cash Flow	-714.54K	-416.18K	-681.05K	-1.03M	-262.81K	-1.79M
Financing Cash Flow	-213.55K	-492.29K	-815.12K	-22.55K	915.98K	3.40M

Adastra Labs Holdings Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.24
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:XTRX, the sentiment is Negative. The current price of 0.24 is above the 20-day moving average (MA) of 0.20, above the 50-day MA of 0.20, and above the 200-day MA of 0.23, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 14.65 is Positive, neither overbought nor oversold. The STOCH value of >-0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:XTRX.

Adastra Labs Holdings Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
OILS	61 Neutral	C$9.29M	8.94	11.57%	―	-1.14%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
STPH	49 Neutral	C$889.83K	-2.15	-13.46%	―	―	―
AVCN	46 Neutral	C$18.85M	-5.08	-68.32%	―	2.41%	74.61%
XTRX	45 Neutral	C$1.12M	-0.52	-6086.85%	―	-33.88%	-449.86%
LABS	45 Neutral	C$29.45M	-3.68	-19.10%	―	18.06%	34.58%
PCLO	45 Neutral	C$6.15M	5.19	―	―	15.64%	58.47%